Detection of carbapenemase-producing Pseudomonas aeruginosa: Evaluation of the carbapenem inactivation method (CIM)
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Dec;37(10):648-651.
doi: 10.1016/j.eimc.2019.02.004.
Epub 2019 Mar 18.
[Article in
English,
Spanish]
Affiliations
- 1 Bacterial Resistance and Hospital Epidemiology Unit, International Center for Medical Research and Training (CIDEIM), Cali, Colombia.
- 2 Bacterial Resistance and Hospital Epidemiology Unit, International Center for Medical Research and Training (CIDEIM), Cali, Colombia; Universidad Santiago de Cali, Cali, Colombia.
- 3 Bacterial Resistance and Hospital Epidemiology Unit, International Center for Medical Research and Training (CIDEIM), Cali, Colombia; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria - RAEH, Universidad El Bosque, Bogotá, Colombia.
- 4 Bacterial Resistance and Hospital Epidemiology Unit, International Center for Medical Research and Training (CIDEIM), Cali, Colombia; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria - RAEH, Universidad El Bosque, Bogotá, Colombia. Electronic address: mariavirginia.villegas@gmail.com.
Abstract
Introduction:
The carbapenem inactivation method (CIM) is a cost-effective assay for detecting carbapenemases. However, its interpretation is unclear for Pseudomonas spp. We evaluate its accuracy when meropenem is changed to imipenem.
Methods:
We analyzed 266 P. aeruginosa isolates. The CIM method consists of: resuspend bacterial colonies (a full 10μL loop) in 400μL water, in which a 10μg disk of meropenem/imipenem is immersed. After 2h of incubation (35°C), remove the disk, place it onto a Mueller-Hinton agar plate previously inoculated with Escherichia coli (ATCC 25922), and incubate at 35 ̊C between 18-24 h. Interpretation criteria (mm of inhibition zone): ≤19mm, positive; ≥25mm negative; 20-24mm, undetermined.
Results:
Imipenem improves the sensitivity and specificity of CIM when compared to meropenem (99.4% and 98.9%, vs. 91.9% and 94.7%, respectively).
Conclusions:
The accuracy of CIM for carbapenemase detection in P. aeruginosa is increased with the use of imipenem.
Keywords:
Carbapenem inactivation method; Carbapenemasas; Carbapenemases; Carbapenemases phenotypic detection; Detección fenotípica; Método de inactivación del carbapenémico; Pruebas de tamizaje; Pseudomonas aeruginosa; Screening test.
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / biosynthesis*
-
Bacteriological Techniques / methods
-
Carbapenems / pharmacology*
-
Humans
-
Meropenem / pharmacology*
-
Microbial Sensitivity Tests / methods
-
Pseudomonas aeruginosa / drug effects*
-
Pseudomonas aeruginosa / enzymology*
-
beta-Lactamases / biosynthesis*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carbapenems
-
beta-Lactamases
-
carbapenemase
-
Meropenem